Related Experiment Video
Updated: Jun 13, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Randomisation in double-blind multicentre trials with many treatments.
Malcolm Morrissey1, Damian McEntegart, Martin Lang
1Perceptive Informatics, Nottingham UK.
Contemporary Clinical Trials
|May 13, 2010
Summary
This study introduces novel randomization methods for complex multicenter clinical trials, aiming to improve treatment allocation control and medication supply management. These advanced techniques enhance trial efficiency and predictability in drug development.
Area of Science:
- Clinical Trials Methodology
- Pharmaceutical Development
- Biostatistics
Background:
- Multicenter trials with multiple treatment arms are common, especially in Phase IIb dose-finding studies.
- Randomization strategies in multicenter trials must consider stratification or balancing by center.
- Key considerations include trial power, predictability, and medication supply logistics.
Purpose of the Study:
- To present and evaluate novel, complex list-based randomization solutions for multicenter trials.
- To demonstrate methods that offer enhanced control over treatment allocations at both the center and study levels.
- To highlight techniques that aid in conserving medication supplies.
Main Methods:
- Description of recently developed and implemented complex list-based randomization techniques.
- Inclusion of two previously unpublished randomization methods.
- Presentation of simulation evidence to evaluate the performance of each technique.
Main Results:
- The described techniques provide varying degrees of control over treatment allocations.
- Methods facilitate better management of medication supplies, crucial for multicenter trials.
- Simulation data supports the efficacy and applicability of the presented randomization solutions.
Conclusions:
- Novel randomization methods can effectively address challenges in complex multicenter trials.
- These techniques improve control over treatment allocation and optimize medication supply management.
- The presented solutions offer valuable tools for efficient and predictable clinical trial conduct.
Related Concept Videos
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.